Vanda Pharmaceuticals (VNDA) Operating Margin (2016 - 2025)
Historic Operating Margin for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to 70.53%.
- Vanda Pharmaceuticals' Operating Margin fell 512000.0% to 70.53% in Q4 2025 from the same period last year, while for Dec 2025 it was 69.95%, marking a year-over-year decrease of 495000.0%. This contributed to the annual value of 69.95% for FY2025, which is 495000.0% down from last year.
- Latest data reveals that Vanda Pharmaceuticals reported Operating Margin of 70.53% as of Q4 2025, which was down 512000.0% from 55.61% recorded in Q3 2025.
- Vanda Pharmaceuticals' Operating Margin's 5-year high stood at 18.22% during Q2 2021, with a 5-year trough of 81.99% in Q1 2025.
- Moreover, its 5-year median value for Operating Margin was 14.09% (2023), whereas its average is 16.28%.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Operating Margin surged by 167200bps in 2021, and later crashed by -625300bps in 2025.
- Vanda Pharmaceuticals' Operating Margin (Quarter) stood at 12.7% in 2021, then decreased by -19bps to 10.28% in 2022, then tumbled by -252bps to 15.67% in 2023, then fell by -23bps to 19.33% in 2024, then crashed by -265bps to 70.53% in 2025.
- Its Operating Margin stands at 70.53% for Q4 2025, versus 55.61% for Q3 2025 and 73.21% for Q2 2025.